Market cap
$6.9b
End-of-day close multiplied by current shares on issue.
Investment income surged 75% to £56.6m and lifted distribution coverage, but the capital account drove another large total-return loss.
Net tangible asset or net asset value per share, shown in per-share cents for chart readability.
Recurring investment-income or revenue-return proxy, excluding fair-value movement where disclosed.
Total income or return including fair-value or capital movement where disclosed.
Net asset base attributable to shareholders or unitholders.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$6.9b
End-of-day close multiplied by current shares on issue.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
1.6%
Trailing dividends compared with the latest close.
Premium / discount
334.0%
For investment companies, price compared with reported NTA.
Total return
Not available
Available once dividend and adjustment data are verified.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not available for this company right now.
EPS
Not available
Not available for this company right now.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not useful for this reporting shape.
P/FCF
Not available
Not available for this company right now.
Key metrics
HY23 vs HY22
Net profit after tax
−$177.3m
+7.6% ↑ vs −$191.8m
Net cash inflow from operating activities
$47.3m
+102.7% ↑ vs $23.4m
Investment income
$56.6m
+75.0% ↑ vs $32.3m
Operating profit
−$168.9m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cash and cash equivalents
$167.1m
+310.1% ↑ vs $40.7m
Total assets
$1.9b
-20.9% ↓ vs $2.4b
What changed
The headline loss narrowed 7.6%, but only because the capital account loss was smaller than a year ago, not because the portfolio turned positive.
Investment income jumped 75.0% to £56.6m from £32.3m, driven by dividends of £55.7m, and that revenue strength flowed through to a doubling of operating cash inflow to £47.3m. The interim dividend was lifted to 2.80 pence per share from 2.00 pence in the prior comparable.
Gross borrowings rose 50.0% to £150.7m, while cash and equivalents climbed to £167.1m from £40.7m, so the trust ended the half with a small net cash position even as gearing was increased.
What matters
The £177.3m total-return loss exists despite a sharp recovery in revenue income, because portfolio fair-value movements remain deeply negative. For a closed-end equity trust, that pattern is normal in a drawdown, but it means the bottom-line "improvement" is a smaller capital loss rather than a turn in portfolio performance.
Distribution coverage strengthened materially. Investment income now covers the declared distribution by roughly 171.8% on the supplied basis, versus 97.8% a year earlier. With prior-period commentary noting that the majority of TEMIT's earnings are typically received in the first half, the cover ratio is supportive of the higher 2.80p interim payment without yet implying full-year sustainability.
Gearing rose into a falling NAV. Bank loans rose to £150.7m from £100.5m while equity shrank 20.9%, so geared exposure as a share of net assets stepped up. Cash on hand is large enough that net debt is slightly negative, but the gross borrowing footprint matters if portfolio drawdowns continue.
Expectations
The trust's own prior-year commentary states that most earnings arrive in the first half, and FY22 confirms that pattern: H1 FY22 investment income of £32.3m represented 59.6% of the full-year £54.3m. Current half-year income of £56.6m already exceeds the entirety of FY22 investment income, which sets a high bar for the second half and means full-year revenue progression will depend on how much was front-loaded by specific dividend timing.
The release does not provide a current-period portfolio-versus-MSCI Emerging Markets attribution that can be cleanly cited, so relative performance against benchmark cannot be assessed in this briefing from the supplied excerpts.
Quality of result
The 75% jump, however, comes from a single half and from a portfolio whose constituents change; without a breakdown of special versus ordinary dividends from investees, it is difficult to know how much repeats.
The bottom-line "improvement" is lower quality. NPAT moved from a £191.9m loss to a £177.3m loss because the unrealised capital loss shrank, not because the portfolio compounded. ROE on the supplied basis remains negative at -9.5% (HY22: -8.1%), and net assets are 20.9% lower than a year earlier. Distribution coverage and revenue earnings are the genuinely strengthened lines; capital return and NAV are not.
Unresolved
This briefing cannot assess current-period portfolio performance relative to the MSCI Emerging Markets benchmark, because the supplied excerpts only quote prior-year comparative returns.
Chat
Ask follow-up questions about Templeton Emerging Markets Investment Trust Plc's HY23 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load analytical metrics.
Open to load key metrics.
Statement of Half-Yearly Results to 30 Sept 22
HY23 / financial reportHalf-year Report
HY22 / financial reportStatement of Annual Results to 31 March 2021
FY22 / financial reportResult of AGM
HY22 / commentaryResult of AGM
HY23 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Get the next Templeton Emerging Markets Investment Trust Plc briefing and related NZX reporting-season updates by email.